Filing Details
- Accession Number:
- 0001209191-20-051631
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-23 09:20:25
- Reporting Period:
- 2020-09-22
- Accepted Time:
- 2020-09-23 09:20:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1359931 | Protara Therapeutics Inc. | TARA | Biological Products, (No Disgnostic Substances) (2836) | 204580525 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1802188 | Blaine Davis | C/O Artara Therapeutics, Inc. 1 Little West 12Th Street New York NY 10014 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-09-22 | 1,481 | $16.91 | 1,481 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.885 to $16.935, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
Billionaire Hedge Funds
